4.4 Article

Glucose-regulated protein 78 is an antiviral against hepatitis A virus replication

Journal

EXPERIMENTAL AND THERAPEUTIC MEDICINE
Volume 13, Issue 6, Pages 3305-3308

Publisher

SPANDIDOS PUBL LTD
DOI: 10.3892/etm.2017.4407

Keywords

CRISPR/Cas9; endoplasmic reticulum stress; glucose-regulated protein 78; hepatitis A virus

Funding

  1. Ministry of Health, Labour and Welfare of Japan
  2. Research Program on Hepatitis from the Japan Agency for Medical Research and Development (AMED)

Ask authors/readers for more resources

Infection with hepatitis A virus (HAV) is a major cause of acute hepatitis globally and it is important to identify the mechanisms of HAV replication. Glucose-regulated protein 78 (GRP78) is an endoplasmic reticulum (ER) chaperone and serves a role in unfolded protein response pathways. Previous studies have demonstrated that GRP78 functions as an endogenous antiviral factor. In the present study, two loss-of-function studies using GRP78 were completed to elucidate the role of GRP78 in HAV infection. HAV replication was observed to be enhanced by deficient GRP78 although GRP78-deficiency also led to lower expression of ER stress molecules downstream of GRP78. Therefore, GRP78 appears to be a potential novel defensive molecule against HAV in hepatocytes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-5/Smad pathway suppression in hepatic stellate cells

Terunao Iwanaga, Tetsuhiro Chiba, Masato Nakamura, Tatsuya Kaneko, Junjie Ao, Na Qiang, Yaojia Ma, Jiaqi Zhang, Tadayoshi Kogure, Sae Yumita, Takamasa Ishino, Keita Ogawa, Motoyasu Kan, Miyuki Nakagawa, Kisako Fujiwara, Naoto Fujita, Takafumi Sakuma, Hiroaki Kanzaki, Keisuke Koroki, Yuko Kusakabe, Masanori Inoue, Kazufumi Kobayashi, Naoya Kanogawa, Soichiro Kiyono, Takayuki Kondo, Ryo Nakagawa, Sadahisa Ogasawara, Shingo Nakamoto, Ryosuke Muroyama, Jun Kato, Tatsuo Kanda, Hitoshi Maruyama, Naoya Mimura, Takuya Honda, Toshihiko Murayama, Hiroyuki Nakamura, Naoya Kato

Summary: This study demonstrates that miglustat can suppress liver fibrosis by inhibiting the TGF-5/Smad pathway, reducing the expression of extracellular matrix components such as collagen. The research also shows that miglustat can both prevent the occurrence of liver fibrosis and reverse established fibrosis.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2023)

Article Gastroenterology & Hepatology

Thirty-two years' experience of treating fulminant hepatitis in a Japanese single center

Keiichi Fujiwara, Shin Yasui, Takayuki Kondo, Masato Nakamura, Makoto Arai, Tatsuo Kanda, Osamu Yokosuka, Masayuki Ohtsuka, Ryuzo Abe, Naoya Kato

Summary: The prognosis of patients with fulminant hepatitis and late-onset hepatic failure in Japan has not improved over the past 32 years, despite advancements in clinical management and liver transplantation. The increasing proportion of patients with poor prognosis and difficult-to-treat etiologies, as well as the aging population, may contribute to this lack of improvement.

HEPATOLOGY RESEARCH (2023)

Article Virology

Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication

Reina Sasaki-Tanaka, Ryota Masuzaki, Hiroaki Okamoto, Toshikatsu Shibata, Mitsuhiko Moriyama, Hirofumi Kogure, Tatsuo Kanda

Summary: This study identified nicotinamide as a potential therapeutic drug for HAV infection by inhibiting HAV replication through suppressing AP-1 activity and HAV IRES-mediated translation.

JOURNAL OF VIROLOGY (2023)

Article Surgery

Tumor stiffness measurement using magnetic resonance elastography can predict recurrence and survival after curative resection of hepatocellular carcinoma

Hayato Abe, Kazu Shibutani, Shintaro Yamazaki, Tatsuo Kanda, Mitsuhiko Moriyama, Masahiro Okada, Masahiko Sugitani, Shingo Tsuji, Tadatoshi Takayama, Yukiyasu Okamura

Summary: This study aimed to investigate the predictive value of preoperative tumor stiffness measured by magnetic resonance elastography on overall survival and recurrence-free survival in patients with hepatocellular carcinoma. The results showed that higher tumor stiffness was associated with increased risk of recurrence and death.

SURGERY (2023)

Article Gastroenterology & Hepatology

Chronic hepatitis E in an elderly immunocompetent patient who achieved a sustained virologic response with ribavirin treatment

Satoshi Takakusagi, Hitoshi Takagi, Yuichi Yamazaki, Takashi Kosone, Shigeo Nagashima, Masaharu Takahashi, Kazumoto Murata, Hiroaki Okamoto

Summary: The article describes a case of autochthonous chronic hepatitis E in a woman in her late 70s who was initially misdiagnosed as having autoimmune hepatitis, but was later found to be caused by hepatitis E virus infection.

CLINICAL JOURNAL OF GASTROENTEROLOGY (2023)

Article Oncology

Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors

Keita Ogawa, Tetsuhiro Chiba, Masato Nakamura, Jun Arai, Jiaqi Zhang, Yaojia Ma, Na Qiang, Junjie Ao, Sae Yumita, Takamasa Ishino, Motoyasu Kan, Terunao Iwanaga, Miyuki Nakagawa, Kisako Fujiwara, Takafumi Sakuma, Hiroaki Kanzaki, Keisuke Koroki, Yuko Kusakabe, Kazufumi Kobayashi, Naoya Kanogawa, Soichiro Kiyono, Takayuki Kondo, Ryo Nakagawa, Sadahisa Ogasawara, Ryosuke Muroyama, Shingo Nakamoto, Tatsuo Kanda, Hitoshi Maruyama, Jun Kato, Shoji Matsumoto, Takayoshi Arai, Shinichiro Motohashi, Naoya Kato

Summary: In this study, the inhibition of ADAM9 was found to prevent the release of MICA and activate the immune function of NK cells. Through the screening of a chemical library, a compound called CCL347 with five benzene rings was identified, which significantly reduced sMICA levels in HCC cell lines and enhanced NK cell cytotoxicity, indicating its potential as a novel therapeutic drug for HCC.

ANTICANCER RESEARCH (2023)

Article Biochemistry & Molecular Biology

Masitinib Inhibits Hepatitis A Virus Replication

Reina Sasaki-Tanaka, Toshikatsu Shibata, Mitsuhiko Moriyama, Hirofumi Kogure, Asuka Hirai-Yuki, Hiroaki Okamoto, Tatsuo Kanda

Summary: In this study, HuhT7-HAV/Luc cells were established as a suitable model for anti-HAV drug screening. Masitinib, a tyrosine kinase inhibitor, was found to reduce HAV replication and internal ribosomal entry-site (IRES) activity. It may be a potential treatment for severe HAV infection.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Gut-Microbiota Dysbiosis in Stroke-Prone Spontaneously Hypertensive Rats with Diet-Induced Steatohepatitis

Shini Kanezawa, Mitsuhiko Moriyama, Tatsuo Kanda, Akiko Fukushima, Ryota Masuzaki, Reina Sasaki-Tanaka, Akiko Tsunemi, Takahiro Ueno, Noboru Fukuda, Hirofumi Kogure

Summary: Metabolic-dysfunction-associated fatty-liver disease (MAFLD) is the leading cause of liver disease worldwide. Nonalcoholic steatohepatitis (NASH) patients have a higher prevalence of small-intestinal bacterial overgrowth (SIBO). In this study, we investigated the differences in gut microbiota between stroke-prone spontaneously hypertensive-5 rats (SHRSP5) fed a normal diet (ND) or a high-fat- and high-cholesterol-containing diet (HFCD). We found an association between MAFLD and gut microbiota alteration, suggesting that targeting gut microbiota may be a potential therapeutic approach for MAFLD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Virology

Development and Characterization of Efficient Cell Culture Systems for Genotype 1 Hepatitis E Virus and Its Infectious cDNA Clone

Putu Prathiwi Primadharsini, Shigeo Nagashima, Toshinori Tanaka, Suljid Jirintai, Masaharu Takahashi, Kazumoto Murata, Hiroaki Okamoto

Summary: HCV-1, a major cause of acute viral hepatitis, has been difficult to study due to its poor replication in cultured cells. A cDNA clone was successfully constructed and an infectious virus was produced, providing a useful tool for studying HCV-1 replication and severe hepatitis in infected pregnant women, as well as for developing safer treatment options.

VIRUSES-BASEL (2023)

Article Gastroenterology & Hepatology

Recent advances in hepatitis A virus research and clinical practice guidelines for hepatitis A virus infection in Japan

Tatsuo Kanda, Reina Sasaki-Tanaka, Koji Ishii, Ryosuke Suzuki, Jun Inoue, Atsunori Tsuchiya, Shingo Nakamoto, Ryuzo Abe, Keiichi Fujiwara, Osamu Yokosuka, Tian-Cheng Li, Satoshi Kunita, Hiroshi Yotsuyanagi, Hiroaki Okamoto

Summary: The Japan Agency for Medical Research and Development (AMED) Hepatitis A and E viruses (HAV and HEV) Study Group has reviewed the recent advances in HAV research and clinical practice for HAV infection in Japan and authored comprehensive guidelines. The article covers virological findings, clinical presentation, pathogenicity, diagnostic approaches, complications, risk factors, preventive measures, and treatment modalities for hepatitis A.

HEPATOLOGY RESEARCH (2023)

Article Gastroenterology & Hepatology

Seroprevalence and incidence of hepatitis E virus infection in the general population of Iwate prefecture, Japan: A retrospective cohort study

Yuichi Yoshida, Asami Ito, Hisashi Eto, Akiko Suzuki, Tamami Abe, Kei Endo, Keisuke Kakisaka, Takayoshi Oikawa, Hidekatsu Kuroda, Akio Miyasaka, Takayuki Matsumoto, Masaharu Takahashi, Hiroaki Okamoto

Summary: This study surveyed the current seroprevalence and incidence of hepatitis E virus (HEV) infection among the general population in Iwate Prefecture, Japan. The findings suggest that the incidence of HEV infection is high and it is a leading cause of hepatitis virus infection in this region.

HEPATOLOGY RESEARCH (2023)

Article Virology

Development of a HiBiT-tagged reporter hepatitis E virus and its utility as an antiviral drug screening platform

Shigeo Nagashima, Putu Prathiwi Primadharsini, Takashi Nishiyama, Masaharu Takahashi, Kazumoto Murata, Hiroaki Okamoto

Summary: This study developed a reporter hepatitis E virus (HEV) and demonstrated its efficient replication, genetic stability, and infectivity. The researchers also simplified the measurement of luciferase activity and used it to evaluate the effects of introducing small interfering RNAs and inhibitors on HEV release. These findings contribute to the understanding of the HEV life cycle and provide a more convenient screening platform for candidate drugs targeting the late stage of HEV infection.

JOURNAL OF VIROLOGY (2023)

Review Virology

Three Distinct Reporter Systems of Hepatitis E Virus and Their Utility as Drug Screening Platforms

Putu Prathiwi Primadharsini, Shigeo Nagashima, Takashi Nishiyama, Hiroaki Okamoto

Summary: Hepatitis E virus (HEV) is recognized as the main cause of acute hepatitis, and the lack of specific antiviral drugs for HEV is a challenge. Researchers have established reporter systems to target different steps of the HEV life cycle and identified potential drug candidates. In vitro tests using a robust cell culture system confirmed the efficacy of these drugs alone or in combination with existing drugs.

VIRUSES-BASEL (2023)

Article Virology

Infection Dynamics and Genomic Mutations of Hepatitis E Virus in Naturally Infected Pigs on a Farrow-to-Finish Farm in Japan: A Survey from 2012 to 2021

Masaharu Takahashi, Satoshi Kunita, Tsutomu Nishizawa, Hiroshi Ohnishi, Putu Prathiwi Primadharsini, Shigeo Nagashima, Kazumoto Murata, Hiroaki Okamoto

Summary: This study investigated the infection dynamics and genomic mutations of HEV in domestic pigs on a farrow-to-finish pig farm in Japan between 2012 and 2021. The results showed active viral replication of HEV in pigs and the presence of HEV RNA in the farm environment. All HEV strains belonged to subgenotype 3b, with a gradual decrease in nucleotide identities over time. Importantly, one HEV strain demonstrated infectivity in human hepatoma cells. These findings contribute to our understanding of HEV prevalence, transmission dynamics, and genetic characteristics.

VIRUSES-BASEL (2023)

No Data Available